Related Experiment Video
Updated: May 14, 2026
10:03
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Genetic susceptibility to meningococcal infection
1Department of Infection & Immunity, University of Sheffield, Medical School, Beech Hill Road, Sheffield, South Yorkshire, S10 2RX, UK. adamdale@doctors.org.uk
Expert Review of Anti-Infective Therapy
|February 16, 2013
Summary
Genetic factors influence susceptibility to meningococcal disease, a serious infection caused by Neisseria meningitidis. Identifying these genetic variants can improve understanding and treatment of this dangerous condition.
Area of Science:
- Immunology
- Genetics
- Infectious Diseases
Background:
- Meningococcal disease is caused by specific Neisseria meningitidis strains.
- Patients often lack bactericidal antibodies, relying on innate immunity or non-bactericidal acquired immunity.
- Genetic variants affecting immune responses are linked to susceptibility and severity.
Purpose of the Study:
- To identify genetic factors influencing host susceptibility and disease severity in meningococcal disease.
- To enhance understanding of the mechanisms underlying meningococcal disease.
- To pave the way for novel therapeutic strategies against Gram-negative sepsis.
Main Methods:
- Analysis of genetic variations in immune response genes.
- Association studies linking gene variants to disease susceptibility.
- Future research will involve large patient cohorts with clinical and demographic data.
Main Results:
- Gene variants in the IL-1 cluster, TNF, SP-A2, and CFH are associated with meningococcal disease susceptibility.
- Genetic factors influence both susceptibility and severity of the disease.
- Understanding these genetic links is crucial for disease management.
Conclusions:
- Genetic variations play a significant role in meningococcal disease.
- Identifying these factors can lead to better treatments for meningococcal disease and Gram-negative sepsis.
- Future research will focus on large-scale genetic analyses for deeper insights.
Related Concept Videos
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:20Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...